Consistent with Apoe as a marker for disease-associated microglia (DAM), in the spatial omics data we observed the expected increase in mRNA and protein APOE level with the presence of amyloid but not tau pathology (Fig. 1e, g) [48]. This evidence concerns the gene APOE and amyloidosis.